Related Experiment Video
Updated: May 27, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
A single institution experience of streptozocin/fluorouracil combination chemotherapy: a case series
J Naidoo1, D O'Toole, M J Kennedy
1Trinity College Dublin, St. James's Hospital, James's Street, Dublin 2, Ireland. jarushka_14@yahoo.com
Background:
The combination chemotherapy regimen of streptozocin and 5-fluorouracil (FU/STZ) has been used for the treatment of metastatic neuroendocrine tumours.
Aim:
The aim of this study was to analyse the use of this regimen in a tertiary oncology referral centre over a 10-year period.
Method:
We retrospectively analysed nine cases from February 2000 to May 2010. Patient demographics, chemotherapy schedule, toxicities, progression-free and overall survival were tabulated for each patient.
Result:
The median progression-free survival was 17 months (range 3-48+ months), and overall survival 31 months (range 12-53+ months) with no toxicity related deaths.
Conclusion:
FU/STZ was a well-tolerated regimen that produced significant benefit in the setting of metastatic and progressive disease. Our case series demonstrated comparable progression-free survival and overall survival in relation to randomized controlled studies and previous case series.
Related Concept Videos
Treatment Resistent Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Chronic Pancreatitis II: Collaborative Care
Assessment:
